Answers are grounded in this paper and cite their sources.
Investigates HtrA1's effects on amyloid precursor protein processing, suggesting links to Alzheimer's disease.
The defining features of the widely conserved HtrA (high temperature requirement) family of serine proteases are the combination of a catalytic protease domain with one or more C-terminal PDZ domains and reversible zymogen activation. Even though HtrAs have previously been implicated in protein quality control and various diseases, including cancer, arthritis, and neuromuscular disorder, the biology of the human family members is not well understood. Our data suggest that HtrA1 is directly involved in the beta-amyloid pathway as it degrades various fragments of amyloid precursor protein while an HtrA1 inhibitor causes accumulation of Abeta in astrocyte cell culture supernatants. Furthermore, HtrA1 colocalizes with beta-amyloid deposits in human brain samples. Potential implications in Alzheimer's disease are discussed.
No takes yet. Share an insight, caveat, or question.
Grau et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: